BioSpace News Archive

Pharm Country

Casana Receives FDA Clearance for Heart Health Smart Toilet Seat

Today, Casana - the industry leader in monitoring heart health through smart toilets - announced receipt of U.S.A. Food and Drug Administration (FDA) clearance of the Heart Seat™ for measuring Heart Rate and Oxygen Saturation (SpO2).

May 1, 2023
·
2 min read
Business

Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced financial results for the first quarter ended March 31, 2023.

May 1, 2023
·
9 min read
Clinical Study Results of the BlueWind System for Patients with Overactive Bladder Featured at the 2023 AUA Annual Meeting

BlueWind Medical, Ltd., the developer of a transformative implantable tibial neuromodulation therapy for Overactive Bladder (OAB), today announced results from the OASIS pivotal trial evaluating the safety and efficacy of the BlueWind System in the treatment of OAB.

May 1, 2023
·
4 min read
Biotech Beach

Lennox-Gastaut Syndrome (LGS) Foundation Hosts 8th Annual Walk ‘n’ Wheel for LGS Research

On May 6, 2023, the Lennox-Gastaut Syndrome (LGS) Foundation will mobilize families, friends, and communities around the world to ‘Step Towards the Cures, Together’ at their 8th Annual Walk ‘n’ Wheel for LGS Research.

May 1, 2023
·
2 min read
Ventus Therapeutics Hosts Inaugural Program Spotlight: VENT-03, a First-in-Class cGAS Inhibitor

Ventus Therapeutics announced today that it will host its inaugural Program Spotlight on VENT-03 on May 25th , 2023 at 11:00 AM ET.

May 1, 2023
·
4 min read
Business

enVVeno Medical Reports First Quarter 2023 Financial Results and Provides Corporate Update

enVVeno Medical Corporation today provided a corporate update and reported financial results for the first quarter ended March 31, 2023.

May 1, 2023
·
6 min read
Genetown

Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of Accugenix® Next Generation Sequencing for Bacterial Identification and Fungal Identification (Accugenix® NGS).

May 1, 2023
·
3 min read
Business

Paratek Pharmaceuticals to Report Financial Results for First Quarter 2023 on May 9

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Tuesday, May 9 at 4:30 p.m. EDT to report financial results for first quarter 2023.

May 1, 2023
·
3 min read
Genetown

Acer Therapeutics Announces OLPRUVA™ Commercial Launch Progressing Ahead of Schedule

Acer Therapeutics Inc. (Nasdaq: ACER) today announced an update on progress in support of its commercial launch of OLPRUVA™ (sodium phenylbutyrate) for oral suspension, including drug availability now expected earlier than anticipated in mid-June 2023, subject to additional capital.

May 1, 2023
·
7 min read
Biotech Beach

New GIMOTI Patent Listed in FDA Orange BookBroad Formulation Patent Expands Protection for Gimoti

Evoke Pharma, Inc. (NASDAQ: EVOK) announced that its recently issued U.S. patent related to GIMOTI, No. 11,628,150 is now listed in the U.S. Food and Drug Administration (FDA) publication, “Approved Drug Products with Therapeutic Equivalence Evaluations”, commonly known as the “Orange Book”.

May 1, 2023
·
6 min read